The city of Salt Lake City, Utah, currently has 16 active clinical trials seeking participants for Diabetes research studies.
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
NCT04897945
Recruiting
Our goal is to test whether shared decision making for diabetes prevention can help women with a history of gestational diabetes mellitus (GDM) who are at high risk of developing type 2 diabetes (T2DM) increase weight loss and adoption of evidence based strategies to lower their risk of incident diabetes.
Gender:
Female
Ages:
Between 18 years and 54 years
Trial Updated:
10/10/2023
Locations: Intermountain Healthcare System, Salt Lake City, Utah
Conditions: Gestational Diabetes Mellitus, Pre-diabetes, Diabetes Mellitus, Type 2
Register for Updates
Circadian Intervention to Improve Cardiometabolic Health
NCT05943626
Recruiting
The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervention is designed to reduce nighttime light exposure and after-dinner snack food intake. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, an... Read More
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
10/09/2023
Locations: College of Health Research Complex--University of Utah, Salt Lake City, Utah
Conditions: Cardiometabolic Syndrome, Type 2 Diabetes, Sleep, Time Restricted Feeding, Lifestyle Factors, Overweight and Obesity, Insulin Sensitivity, Eating Habit, Sleep Hygiene
Register for Updates
Study of Pregnancy And Neonatal Health (SPAN)
NCT05515744
Recruiting
This study will conduct a randomized trial among women with gestational diabetes (GDM). Study of Pregnancy And Neonatal health (SPAN), TIMing of dElivery (TIME) is a randomized trial that will recruit up to 3,450 pregnant women with uncontrolled GDM and randomize the timing of their delivery. Women with GDM who are approached for the trial and are found eligible but do not consent to participating in randomization for delivery will be asked to consent for chart review only (estimated additional... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/26/2023
Locations: University of Utah, Salt Lake City, Utah
Conditions: Gestational Diabetes Mellitus
Register for Updates
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05579314
Recruiting
This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-human (FIH) study to evaluate the safety, tolerability, food effect (FE), pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered XW014 in healthy participants and patients with T2DM. This study will consist of 3 parts: a Single Ascending Dose (SAD) part in healthy subjects (Part A), and Multiple Ascending Dose (MAD) parts in healthy subjects with elevated BMI (Part B) and patients with T2DM (Part C).
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
08/14/2023
Locations: ICON - Early Development Services, Salt Lake City, Utah
Conditions: Type 2 Diabetes Mellitus
Register for Updates